BCL2L2 KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon3 and Insertion of the selection cassette in exon3.
HeLa
Human
Cervix
Sanger Sequencing, Western blot
Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon3 and Insertion of the selection cassette in exon3.
Apoptosis regulator Bcl-W, B2CL2_HUMAN, BCL 2 Like 2, BCL W, Bcl 2 like 2 protein, Bcl-2-like protein 2, Bcl2-L-2, KIAA0271, PPP1R51, Protein phosphatase 1 regulatory subunit 51
BCL2L2 KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon3 and Insertion of the selection cassette in exon3.
HeLa
Human
Cervix
Sanger Sequencing, Western blot
Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon3 and Insertion of the selection cassette in exon3.
Adenocarcinoma
BCL2L2
Knockout
CRISPR technology
Sanger Sequencing, Western blot
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
EU: 2 US: 2
Adherent
Female
Ambient - Can Ship with Ice
-20°C
-20°C
Knockout cell lysate achieved by CRISPR/Cas9.
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.
This supplementary information is collated from multiple sources and compiled automatically.
Bcl2L2 also known as Bcl-w is a protein that functions as an anti-apoptotic member of the Bcl-2 family. It has a molecular weight of approximately 21 kDa. This protein is expressed in various tissues such as the brain testis and kidney suggesting it plays a significant role in these organs. Bcl2L2's expression pattern and structure contribute to its function in regulating apoptotic pathways by inhibiting cell death signals.
The function of Bcl-w involves its role in promoting cell survival. It is part of a complex network of interactions within the Bcl-2 family. This protein family includes both pro-apoptotic and anti-apoptotic proteins and Bcl-w helps maintain the balance by impeding apoptosis. The protein localizes to the mitochondrial outer membrane where it sequesters pro-apoptotic members such as Bax and Bak preventing the release of cytochrome c an essential step in the apoptosis process.
The Bcl-w protein integrates into the intrinsic mitochondrial apoptosis pathway. It interacts closely with other Bcl-2 family proteins to ensure cellular homeostasis. Important pathways involving Bcl-w include the mitochondrial or intrinsic apoptosis pathway and the PI3K/AKT signaling pathway both of which regulate cell survival. Related proteins include Bcl-2 Bcl-XL Bax and Bak. These proteins collectively modulate the apoptosis signaling and therefore influence cell fate decisions within tissues where Bcl-w is expressed.
Bcl-w has been implicated in cancer and neurodegenerative diseases due to its role in cell survival and apoptosis regulation. In certain cancers the overexpression of Bcl-w protein can lead to unchecked cell proliferation by avoiding apoptosis therefore promoting tumor growth. In neurodegenerative diseases such as Alzheimer's disease altered expression of Bcl-w may contribute to neuronal survival affecting disease progression. Proteins like Bax and Bak which promote apoptosis are often in regulatory interplay with Bcl-w in these conditions highlighting the delicate balance of pro-survival and pro-apoptotic forces in disease states.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Lane 1: Wild-type HeLa cell lysate 40 μg
Lane 2: BCL2L2 knockout HeLa cell lysate 40 μg
Lane 3: HepG2 cell lysate 40 μg
Lane 4: MOLT-4 cell lysate 40 μg
False colour image of Western blot: Anti-BCL2L2 antibody staining at 1/500 dilution, shown in green; loading control Anti-alpha Tubulin antibody [DM1A] - Loading Control ab7291 (Mouse anti-Alpha Tubulin [DM1A]) staining at 1/20000 dilution, shown in red. In Western blot, the antibody was shown to bind specifically to BCL2L2. A band was observed at 17 kDa in wild-type HeLa cell lysates with no signal observed at this size in BCL2L2 knockout cell line Human BCL2L2 knockout HeLa cell line ab265368 (knockout cell lysate ab258325). To generate this image, wild-type and BCL2L2 knockout HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776) at 1/20000 dilution.
All lanes: anti-BCL2L2 antibody at 1/500 dilution
Lane 1: Wild-type HeLa cell lysate at 40 µg
Lane 2: BCL2L2 knockout HeLa cell lysate at 40 µg
Lane 3: HepG2 cell lysate at 40 µg
Lane 4: MOLT-4 cell lysate at 40 µg
Performed under reducing conditions.
False colour image of Western blot: Anti-BCL2L2 antibody staining at 1/500 dilution, shown in green; loading control Anti-alpha Tubulin antibody [DM1A] - Loading Control ab7291 (Mouse anti-Alpha Tubulin [DM1A]) staining at 1/20000 dilution, shown in red. In Western blot, the antibody was shown to bind specifically to BCL2L2. A band was observed at 17 kDa in wild-type HeLa cell lysates with no signal observed at this size in BCL2L2 knockout cell line Human BCL2L2 knockout HeLa cell line ab265368 (knockout cell lysate ab258325). To generate this image, wild-type and BCL2L2 knockout HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776) at 1/20000 dilution.
All lanes: Anti-BCL2L2 antibody at 1/500 dilution
Lane 1: Wild-type HeLa cell lysate at 40 µg
Lane 2: BCL2L2 knockout HeLa cell lysate at 40 µg
Lane 3: HepG2 cell lysate
Lane 4: MOLT-4 cell lysate at 40 µg
Lanes 1 - 4: Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773) at 1/20000 dilution
Lanes 1 - 4: Western blot - Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776) at 1/20000 dilution
Performed under reducing conditions.
Observed band size: 17 kDa
Allele-1: 1 bp insertion in exon3
Allele-2: Insertion of the selection cassette in exon3
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com